InvestorQ : I had 300 Biocon shares and want to invest 200 more. Recently there is news about IPO of one of it's subsidiary BIOCON BIOLOGICS. What will be the impact of this IPO on shareholders of BIOCON? What should be strategy for the short term?
Ashit made post

I had 300 Biocon shares and want to invest 200 more. Recently there is news about IPO of one of it's subsidiary BIOCON BIOLOGICS. What will be the impact of this IPO on shareholders of BIOCON? What should be strategy for the short term?

Answer
image
Arya Nanda answered.
1 year ago
Follow

Biocon stock looks good due to its strong focus on biosimilars and on contract research. The company is less vulnerable to FDA related issues and to that extent its business model is more diversified compared to other pharma stories. You can look to buy Biocon from a long term perspective, although the IPO of a subsidiary is unlikely to substantially impact the valuations of the company.

5 Views